Bon Natural Life Valuation
Is BON undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of BON when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate BON's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate BON's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for BON?
Key metric: As BON is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is BON's PE Ratio? | |
|---|---|
| PE Ratio | 2.4x |
| Earnings | US$2.47m |
| Market Cap | US$5.36m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 0.5x |
| Enterprise Value/EBITDA | 2.7x |
| PEG Ratio | n/a |
Price to Earnings Ratio vs Peers
How does BON's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 32.9x | ||
FSI Flexible Solutions International | 11.8x | 2.2% | US$49.2m |
NTIC Northern Technologies International | 24.3x | 23.7% | US$132.7m |
NANX Nanophase Technologies | 67.2x | n/a | US$188.3m |
FTK Flotek Industries | 28.4x | 34.5% | US$243.6m |
BON Bon Natural Life | 2.4x | n/a | US$5.4m |
Price-To-Earnings vs Peers: BON is good value based on its Price-To-Earnings Ratio (2.4x) compared to the peer average (32.9x).
Price to Earnings Ratio vs Industry
How does BON's PE Ratio compare vs other companies in the US Chemicals Industry?
| 7 Companies | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
| Industry Avg. | 23.2x | 16.8% | |
BON Bon Natural Life | 2.4x | n/a | US$5.36m |
FFHL Fuwei Films (Holdings) | 2.8x | n/a | US$27.11m |
BSLK Bolt Projects Holdings | 0.06x | n/a | US$9.40m |
| 7 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
| Industry Avg. | 23.2x | 16.8% | |
BON Bon Natural Life | 2.4x | n/a | US$5.36m |
Price-To-Earnings vs Industry: BON is good value based on its Price-To-Earnings Ratio (2.4x) compared to the US Chemicals industry average (22.6x).
Price to Earnings Ratio vs Fair Ratio
What is BON's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 2.4x |
| Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate BON's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Ecora Resources
UK£159.8m
Operates as a natural resource royalty and streaming company in Australia, North and South America, Europe, and internationally.
ECRA.F
UK£0.85
7D
10.4%
1Y
-22.7%
Huntsman
US$3.3b
Manufactures and sells diversified organic chemical products worldwide.
HUN
US$19.42
7D
-1.3%
1Y
-22.1%
Chemtrade Logistics Income Fund
CA$1.4b
Offers industrial chemicals and services in Canada, the United States, and South America.
CGIF.F
CA$8.20
7D
4.0%
1Y
30.0%